Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: Q4Q8S2
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0016485 | protein processing | 5 | 11 |
GO:0019538 | protein metabolic process | 3 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0051604 | protein maturation | 4 | 11 |
GO:0071586 | CAAX-box protein processing | 6 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004175 | endopeptidase activity | 4 | 11 |
GO:0004222 | metalloendopeptidase activity | 5 | 11 |
GO:0008233 | peptidase activity | 3 | 11 |
GO:0008237 | metallopeptidase activity | 4 | 11 |
GO:0016787 | hydrolase activity | 2 | 11 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 88 | 90 | PF00675 | 0.444 |
CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.444 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.479 |
DEG_APCC_DBOX_1 | 78 | 86 | PF00400 | 0.244 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.579 |
DOC_CKS1_1 | 54 | 59 | PF01111 | 0.316 |
DOC_PP1_RVXF_1 | 77 | 84 | PF00149 | 0.270 |
DOC_PP4_FxxP_1 | 41 | 44 | PF00568 | 0.397 |
DOC_PP4_FxxP_1 | 54 | 57 | PF00568 | 0.435 |
DOC_WW_Pin1_4 | 53 | 58 | PF00397 | 0.435 |
DOC_WW_Pin1_4 | 88 | 93 | PF00397 | 0.251 |
LIG_14-3-3_CanoR_1 | 196 | 201 | PF00244 | 0.632 |
LIG_14-3-3_CanoR_1 | 22 | 27 | PF00244 | 0.604 |
LIG_14-3-3_CanoR_1 | 32 | 41 | PF00244 | 0.448 |
LIG_14-3-3_CanoR_1 | 88 | 92 | PF00244 | 0.242 |
LIG_14-3-3_CanoR_1 | 94 | 104 | PF00244 | 0.273 |
LIG_EH1_1 | 143 | 151 | PF00400 | 0.366 |
LIG_FHA_1 | 35 | 41 | PF00498 | 0.267 |
LIG_FHA_1 | 58 | 64 | PF00498 | 0.261 |
LIG_FHA_2 | 197 | 203 | PF00498 | 0.535 |
LIG_LIR_Apic_2 | 53 | 57 | PF02991 | 0.447 |
LIG_LIR_Gen_1 | 6 | 17 | PF02991 | 0.630 |
LIG_LIR_Nem_3 | 153 | 159 | PF02991 | 0.320 |
LIG_LIR_Nem_3 | 189 | 193 | PF02991 | 0.515 |
LIG_LIR_Nem_3 | 6 | 12 | PF02991 | 0.618 |
LIG_LIR_Nem_3 | 75 | 81 | PF02991 | 0.253 |
LIG_NRBOX | 154 | 160 | PF00104 | 0.397 |
LIG_NRBOX | 81 | 87 | PF00104 | 0.262 |
LIG_Pex14_2 | 152 | 156 | PF04695 | 0.355 |
LIG_Pex14_2 | 96 | 100 | PF04695 | 0.486 |
LIG_SH2_CRK | 78 | 82 | PF00017 | 0.366 |
LIG_SH2_SRC | 164 | 167 | PF00017 | 0.326 |
LIG_SH2_STAT5 | 210 | 213 | PF00017 | 0.309 |
LIG_SH2_STAT5 | 67 | 70 | PF00017 | 0.301 |
LIG_SH2_STAT5 | 9 | 12 | PF00017 | 0.624 |
LIG_SH3_3 | 65 | 71 | PF00018 | 0.320 |
LIG_TYR_ITIM | 76 | 81 | PF00017 | 0.360 |
LIG_WW_3 | 15 | 19 | PF00397 | 0.570 |
MOD_CDC14_SPxK_1 | 91 | 94 | PF00782 | 0.195 |
MOD_CDK_SPxK_1 | 88 | 94 | PF00069 | 0.182 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.430 |
MOD_CK2_1 | 196 | 202 | PF00069 | 0.544 |
MOD_CMANNOS | 219 | 222 | PF00535 | 0.172 |
MOD_GlcNHglycan | 140 | 143 | PF01048 | 0.349 |
MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.371 |
MOD_GlcNHglycan | 205 | 208 | PF01048 | 0.342 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.417 |
MOD_GlcNHglycan | 97 | 100 | PF01048 | 0.374 |
MOD_GSK3_1 | 192 | 199 | PF00069 | 0.529 |
MOD_GSK3_1 | 30 | 37 | PF00069 | 0.472 |
MOD_GSK3_1 | 53 | 60 | PF00069 | 0.312 |
MOD_NEK2_1 | 100 | 105 | PF00069 | 0.299 |
MOD_NEK2_2 | 57 | 62 | PF00069 | 0.246 |
MOD_PKA_2 | 21 | 27 | PF00069 | 0.661 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.521 |
MOD_PKA_2 | 87 | 93 | PF00069 | 0.286 |
MOD_PKB_1 | 194 | 202 | PF00069 | 0.503 |
MOD_Plk_1 | 168 | 174 | PF00069 | 0.311 |
MOD_Plk_1 | 57 | 63 | PF00069 | 0.336 |
MOD_Plk_4 | 22 | 28 | PF00069 | 0.668 |
MOD_Plk_4 | 34 | 40 | PF00069 | 0.255 |
MOD_ProDKin_1 | 53 | 59 | PF00069 | 0.427 |
MOD_ProDKin_1 | 88 | 94 | PF00069 | 0.251 |
MOD_SUMO_rev_2 | 116 | 126 | PF00179 | 0.594 |
TRG_ENDOCYTIC_2 | 164 | 167 | PF00928 | 0.261 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.375 |
TRG_ENDOCYTIC_2 | 9 | 12 | PF00928 | 0.662 |
TRG_ER_diArg_1 | 193 | 196 | PF00400 | 0.544 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HYS3 | Leptomonas seymouri | 48% | 79% |
A0A0S4JSY4 | Bodo saltans | 35% | 72% |
A0A1X0NYX6 | Trypanosomatidae | 36% | 74% |
A0A3S7X0B2 | Leishmania donovani | 92% | 100% |
A4HFB3 | Leishmania braziliensis | 70% | 79% |
A4I2J5 | Leishmania infantum | 91% | 100% |
C9ZK27 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 74% |
E9AYQ0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
V5BHT4 | Trypanosoma cruzi | 30% | 93% |